☰
  • Request an Appointment
  • Get a Second Opinion
  • Share Your Story
  • Donate
Close
  • Home
  • Research
  • Patient Stories
  • Parenting
  • Clinical Care
  • Our Community
  • Request an Appointment
  • Get a Second Opinion
  • Share Your Story
  • Donate

Answers
Your destination for kids' health

SARS-CoV-2 spike protein in its two conformations

Capturing SARS-CoV-2’s shape-shifting spike protein

Basic/Translational, Research
The rod-like spike proteins on the surface of SARS CoV-2 are the tip of the spear of the COVID-19 pandemic. The spikes bind to human cells via the ACE2 receptor and then dramatically change shape. They jack-knife, folding in on themselves to fuse their own membrane with the membrane of our cells. And that opens ... Read More about Capturing SARS-CoV-2’s shape-shifting spike protein
Tagged: cellular and molecular medicine, coronavirus, imaging, infectious diseases
diving deep into ependymoma and its cellular origins

Diving into the dark side of ependymoma

Basic/Translational, Research
Mariella Filbin, MD, PhD, a neuro-oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, is driven by a desire to find new therapies for some of the hardest-to-treat pediatric brain tumors. At the core of her work is an effort to uncover the events that shape tumor development. Key takeaways:·      Aggressive ependymoma tumors are stuck ... Read More about Diving into the dark side of ependymoma
Tagged: brain tumor, cancer, epigenetics, genetics and genomics
tuberous sclerosis giant cell

New drug pathway linked with tuberous sclerosis

Basic/Translational, Research
Tuberous sclerosis complex (TSC) is a neurological disorder causing non-cancerous tumors, called cortical tubers, to grow throughout the brain and body, as well as other conditions like epilepsy and autism. While medications are used to treat some of the manifestations of the disease, safe and more effective treatments targeting disease at a fundamental level are ... Read More about New drug pathway linked with tuberous sclerosis
Tagged: rare disease, tuberous sclerosis
interferon COVID-19 inflammation concept

Type III interferon in COVID-19: Protective or harmful?

Basic/Translational, Research
Our immune system makes interferons and other cytokines to help us fight viruses. But in COVID-19, we’ve learned that they can also contribute to damaging, potentially life-threatening lung inflammation. New work published yesterday in the journal Science helps tease out the good from the bad for one interferon of interest: type III. Key takeaways. At ... Read More about Type III interferon in COVID-19: Protective or harmful?
Tagged: coronavirus, immunology, infectious diseases
skin organoid growing human hair follicles embedded with nerve cells

Creating hairy human skin: Not as easy as you think

Basic/Translational, Research
Key takeaways·      Scientists have created the first cultured human skin capable of growing hair embedded with fat and nerve cells. ·      Potential applications include burn treatments, and testing medications and cosmetics·      The skin organoid system developed is a proof of concept for creating other human organoids, such as the inner ear. For more than 40 ... Read More about Creating hairy human skin: Not as easy as you think
Tagged: hearing, organoids, otolaryngology, plastic surgery, stem cells, tissue engineering
graphic image of mouse and cochlea

Gene therapy with a new base editing technique restores hearing in mice

Basic/Translational, Research
Using a new genetic engineering technique, known as base editing, researchers from Boston Children’s Hospital and the Broad Institute of MIT and Harvard, have restored hearing in mice with a known recessive genetic mutation. Key takeaways·      This is the first example of repairing a recessive gene mutation.·      Repairing a single mutation in the Tmc1 gene restored partial hearing in ... Read More about Gene therapy with a new base editing technique restores hearing in mice
Tagged: gene therapy, hearing
mouse with barcodes, tracking development with barcodes

Tracking an organism’s development, cell by cell

Basic/Translational, Research
A new mouse model allows scientists to track every cell in the body — from the embryo stage until adulthood. The system is the first of its kind and should yield a greater understanding of development, aging, and disease. Scientists described it last week in the journal Cell. “The dream of many developmental biologists for ... Read More about Tracking an organism’s development, cell by cell
Tagged: aging, biomarkers, blood, cellular and molecular medicine, genetics and genomics, hematology, laboratory tools, stem cells
disulfiram structure

Disulfiram inhibits inflammatory gatekeeper protein: Could it be helpful in COVID-19?

Basic/Translational, Research
Inflammation is the alarm system by which cells first respond to potential danger. But in excess, inflammation can be deadly. In new research from the Program in Cellular and Molecular Medicine (PCCM) at Boston Children’s Hospital, scientists discovered that disulfiram, an FDA-approved drug commonly used for treating alcoholism, blocks a key gatekeeper protein involved in ... Read More about Disulfiram inhibits inflammatory gatekeeper protein: Could it be helpful in COVID-19?
Tagged: coronavirus, immunology
Brad Martin (now deceased), a patient with dyskeratosis congenita who donated his cells to research on telomere diseases.

A drug treatment for telomere diseases?

Basic/Translational, Research
For years, Donna Martin carried a piece of scrap paper with the words “dyskeratosis congenita,” which she believed might explain her son Brad’s sudden, mysterious affliction. A routine blood test had revealed Brad’s bone marrow was failing, unable to keep up with his need for healthy blood cells. His condition, Donna knew, would worsen over ... Read More about A drug treatment for telomere diseases?
Tagged: aging, anemia, blood, cellular and molecular medicine, drug development, dyskeratosis congenita, rare disease, telomere disease
cancer immunotherapy: cancer cells with and without gasdermin E

Gasdermin E: A new approach to cancer immunotherapy

Basic/Translational, Research
Tumors have figured out various ways to prevent the immune system from attacking them. Medicine, for its part, has fought back with cancer immunotherapy. The major approach uses checkpoint inhibitors, drugs that help the immune system recognize cancer cells as foreign. Another method, CAR T-cell therapy, directly engineers peoples’ T cells to efficiently recognize cancer ... Read More about Gasdermin E: A new approach to cancer immunotherapy
Tagged: cancer, cellular and molecular medicine, immunotherapy

Posts navigation

Older posts
Newer posts

Stay connected!

Sign up to receive email updates from Boston Children’s, including parenting tips, patient stories, helpful resources, and news for your family.

 

Subscribe now
Clinical Trials
Connect With Boston Children’s Hospital
U.S. News Badge Newsweek Badge
    • 300 Longwood Avenue, Boston, MA 02115

    • 617-355-6000 800-355-7944

  • How Can We Help

    • International Visitors
    • Centers and Services
    • Conditions + Treatments
    • Find a Doctor
    • Get a Second Opinion
    • Locations
  • About

    • About Us
    • Giving to Boston Children’s
    • Newsroom
    • Quality & Patient Safety
  • Legal

    • HIPAA Notice of Privacy Practices
    • Patient & Family Rights
    • Terms of Use
    • Public Policy